Quarterly report pursuant to Section 13 or 15(d)

Marketable Securities (Details)

v3.20.2
Marketable Securities (Details) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Schedule of Available-for-sale Securities [Line Items]    
Cost Basis   $ 2,995,136
Gross Unrealized Gains   2,084
Fair Value $ 0 2,997,220
Commercial Paper [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Cost Basis   1,996,216
Gross Unrealized Gains   1,184
Fair Value   1,997,400
Corporate Bonds [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Cost Basis   998,920
Gross Unrealized Gains   900
Fair Value   $ 999,820